Home
The War on Cancer
Cancer A – Z
Drug Approvals 2017
Articles
Conference Coverage
Editorial
Eric Rosenthal Reports
Expert Interview
Latest Articles
Publications
News
The Onco’Zine Brief
The Onco’Zine Brief Episodes
Upcoming Programs | Shows
How to Support The Onco’Zine Brief
Underwriting
The Onco’Zine Brief on PRX
The Onco’Zine Brief on Spreaker
Programs | Shows
Oncology Directory
Join Today
Event Agenda
Video
Search
About
Advertise
Advisory Board
Contact Us
Onco'Zine
Home
The War on Cancer
Cancer A – Z
Drug Approvals 2017
Articles
Conference Coverage
Editorial
Eric Rosenthal Reports
Expert Interview
Latest Articles
Publications
News
The Onco’Zine Brief
The Onco’Zine Brief Episodes
Upcoming Programs | Shows
How to Support The Onco’Zine Brief
Underwriting
The Onco’Zine Brief on PRX
The Onco’Zine Brief on Spreaker
Programs | Shows
Oncology Directory
Join Today
Event Agenda
Video
Home
Latest Articles
Latest Articles
Research Shows Molecular Engine That Drives Pancreatic Cancer and Ways to Turn It Off
Peter Hofland, Ph.D
-
August 22, 2019
Researchers Find New Way to Treat Aggressive form of Brain Tumor
US FDA to Review Isatuximab as a Potential Treatment for R/R Multiple Myeloma
While Oncologists? Pay Attention to Patients? Weight Management and Diet they Infrequently Refer to Support Lifestyle Changes
Daiichi Sankyo Accelerates Biologics License Application for Trastuzumab Deruxtecan
Oxybutynin Improved Quality of Life for Breast Cancer Survivors
Peter Hofland, Ph.D
-
December 8, 2018
Investigational Compound from Chinese Tree Bark Shows Potential as Treatment for...
Peter Hofland, Ph.D
-
November 7, 2018
Oral Sores and Cancer Treatment
Alisa Cooper Wechsler
-
May 11, 2018
First-line Treatment with Pembrolizumab
Peter Hofland, Ph.D
-
April 16, 2018
First Patients Enrolled in Landmark Lung Cancer Tri-Therapy Clinical Trial
Peter Hofland, Ph.D
-
January 19, 2018
Charitable Efforts Know No Boundaries When Helping the Underserved? Stakeholders Strive...
Eric T. Rosenthal
-
September 25, 2017
Anti-Leukemic Activity and Safety Data for Gilteritinib in Relapsed
Peter Hofland, Ph.D
-
June 23, 2017
Eric Rosenthal Reports: Placing Cancer Fear in its Proper Perspective
Eric T. Rosenthal
-
June 21, 2017
Palbociclib may have Wider Applicability in Targeting Cancer
Peter Hofland, Ph.D
-
June 15, 2017
First Immunotherapy Expected for the treatment of Malignant Pleural Mesothelioma
Peter Hofland, Ph.D
-
June 9, 2017
1
2
Page 1 of 2
LATEST
ESMO 2019: Seattle Genetics to Present Latest Study Data – Becomes Multi-product Oncology Company
Peter Hofland, Ph.D
-
September 17, 2019
Biologics License Application and Priority Review for Enfortumab Vedotin in Urothelial Cancer
Peter Hofland, Ph.D
-
September 16, 2019
Varian’s Adaptive Therapy Provides Opportunity to Transform Radiation Oncology
Peter Hofland, Ph.D
-
September 15, 2019
